Study links stronger antibody responses to more severe COVID-19
Photo Cred: Gustavo Fring/Pexels By Katherine Shagoury Sex, age, and severity of disease may be useful in identifying novel coronavirus (COVID-19) survivors who are likely to have high levels of...
Read MoreCOVID-19 antibodies could last at least three months, study suggests
Photo Cred: ThisIsEngineering/Pexels By Katherine Shagoury Novel coronavirus (COVID-19) antibodies can last at least three months after a person becomes infected with SARS-CoV-2, the virus that causes COVID-19, according to...
Read MoreResearchers identify bacteria linked with changes in gut microbiome of infants
Photo Cred: Andreas Wohlfahrt/Pexels By Katherine Shagoury Events at birth may affect the microbes living in a baby’s gut during the first few months of life, leading to a higher...
Read MoreLink between blood type and COVID-19 susceptibility, study finds
Photo Cred: Edward Jenner/Pexels By Katherine Shagoury People with blood type O may have a lower risk of novel coronavirus (COVID-19) infection and reduced likelihood of severe outcomes, including organ...
Read MoreDried blood spot sampling potential for COVID-19 antibody testing
Photo Cred: University of Birmingham By Katherine Shagoury Using dried blood spot samples is an accurate alternative to venous blood in detecting SARS-CoV-2, the virus that causes the novel coronavirus...
Read MoreLow immunity linked to poor outcomes in HIV patients who contract COVID-19
Photo Cred: Justin Kelley By Katherine Shagoury Patients with human immunodeficiency virus (HIV) are susceptible to the novel coronavirus (COVID-19), and certain factors increase the risk of hospitalization and death,...
Read MoreSevere COVID-19 cases may be explained by genetic defects
Photo Cred: ThisisEngineering RAEng/Unsplash By Katherine Shagoury A proportion of the most severe novel coronavirus (COVID-19) cases can be explained by genetic defects in the patients’ immune system, according to...
Read MoreResearchers validate clinical feasibility for COVID-19 testing
Photo Cred: Karolina Grabowska/Pexels By Katherine Shagoury A team of researchers from the University of Connecticut validated the clinical feasibility of the All-In-One-Dual CRISPR-Cas12a (AIOD-CRISPR) method for rapid, ultrasensitive, visual...
Read More